CFLT vs DNTH · rev $963.6M vs rev $6.2M
Confluent Inc (CFLT) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
CFLT currently screens at market cap $11.13B. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the CFLT and DNTH stock pages for the full models.
Not investment advice.